Literature references that cite this PDB file's
key reference
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
E.Giurisato,
J.Lin,
A.Harding,
E.Cerutti,
M.Cella,
R.E.Lewis,
M.Colonna,
and
A.S.Shaw
(2009).
The mitogen-activated protein kinase scaffold KSR1 is required for recruitment of extracellular signal-regulated kinase to the immunological synapse.
|
| |
Mol Cell Biol, 29,
1554-1564.
|
 |
|
|
|
|
 |
C.A.Kraft,
J.L.Garrido,
E.Fluharty,
L.Leiva-Vega,
and
G.Romero
(2008).
Role of Phosphatidic Acid in the Coupling of the ERK Cascade.
|
| |
J Biol Chem, 283,
36636-36645.
|
 |
|
|
|
|
 |
L.R.Jagemann,
L.G.Pérez-Rivas,
E.J.Ruiz,
J.A.Ranea,
F.Sánchez-Jiménez,
A.R.Nebreda,
E.Alba,
and
J.Lozano
(2008).
The functional interaction of 14-3-3 proteins with the ERK1/2 scaffold KSR1 occurs in an isoform-specific manner.
|
| |
J Biol Chem, 283,
17450-17462.
|
 |
|
|
|
|
 |
P.V.Escribá,
J.M.González-Ros,
F.M.Goñi,
P.K.Kinnunen,
L.Vigh,
L.Sánchez-Magraner,
A.M.Fernández,
X.Busquets,
I.Horváth,
and
G.Barceló-Coblijn
(2008).
Membranes: a meeting point for lipids, proteins and therapies.
|
| |
J Cell Mol Med, 12,
829-875.
|
 |
|
|
|
|
 |
A.Clapéron,
and
M.Therrien
(2007).
KSR and CNK: two scaffolds regulating RAS-mediated RAF activation.
|
| |
Oncogene, 26,
3143-3158.
|
 |
|
|
|
|
 |
D.R.Dries,
L.L.Gallegos,
and
A.C.Newton
(2007).
A single residue in the C1 domain sensitizes novel protein kinase C isoforms to cellular diacylglycerol production.
|
| |
J Biol Chem, 282,
826-830.
|
 |
|
|
|
|
 |
M.M.McKay,
and
D.K.Morrison
(2007).
Integrating signals from RTKs to ERK/MAPK.
|
| |
Oncogene, 26,
3113-3121.
|
 |
|
|
|
|
 |
T.E.Fox,
K.L.Houck,
S.M.O'Neill,
M.Nagarajan,
T.C.Stover,
P.T.Pomianowski,
O.Unal,
J.K.Yun,
S.J.Naides,
and
M.Kester
(2007).
Ceramide recruits and activates protein kinase C zeta (PKC zeta) within structured membrane microdomains.
|
| |
J Biol Chem, 282,
12450-12457.
|
 |
|
|
|
|
 |
A.Mor,
and
M.R.Philips
(2006).
Compartmentalized Ras/MAPK signaling.
|
| |
Annu Rev Immunol, 24,
771-800.
|
 |
|
|
|
|
 |
S.E.Robertson,
S.R.Setty,
A.Sitaram,
M.S.Marks,
R.E.Lewis,
and
M.M.Chou
(2006).
Extracellular signal-regulated kinase regulates clathrin-independent endosomal trafficking.
|
| |
Mol Biol Cell, 17,
645-657.
|
 |
|
|
|
|
 |
Y.Pu,
M.L.Peach,
S.H.Garfield,
S.Wincovitch,
V.E.Marquez,
and
P.M.Blumberg
(2006).
Effects on ligand interaction and membrane translocation of the positively charged arginine residues situated along the C1 domain binding cleft in the atypical protein kinase C isoforms.
|
| |
J Biol Chem, 281,
33773-33788.
|
 |
|
|
|
|
 |
M.A.White,
and
R.G.Anderson
(2005).
Signaling networks in living cells.
|
| |
Annu Rev Pharmacol Toxicol, 45,
587-603.
|
 |
|
|
|
|
 |
R.V.Stahelin,
J.Wang,
N.R.Blatner,
J.D.Rafter,
D.Murray,
and
W.Cho
(2005).
The origin of C1A-C2 interdomain interactions in protein kinase Calpha.
|
| |
J Biol Chem, 280,
36452-36463.
|
 |
|
|
|
|
 |
R.Kolesnick,
and
H.R.Xing
(2004).
Inflammatory bowel disease reveals the kinase activity of KSR1.
|
| |
J Clin Invest, 114,
1233-1237.
|
 |
|
|
|
|
 |
D.K.Morrison,
and
R.J.Davis
(2003).
Regulation of MAP kinase signaling modules by scaffold proteins in mammals.
|
| |
Annu Rev Cell Dev Biol, 19,
91.
|
 |
|
|
|
|
 |
F.X.Contreras,
A.V.Villar,
A.Alonso,
R.N.Kolesnick,
and
F.M.Goñi
(2003).
Sphingomyelinase activity causes transbilayer lipid translocation in model and cell membranes.
|
| |
J Biol Chem, 278,
37169-37174.
|
 |
|
|
|
|
 |
J.Müller,
D.A.Ritt,
T.D.Copeland,
and
D.K.Morrison
(2003).
Functional analysis of C-TAK1 substrate binding and identification of PKP2 as a new C-TAK1 substrate.
|
| |
EMBO J, 22,
4431-4442.
|
 |
|
|
|
|
 |
P.L.Channavajhala,
L.Wu,
J.W.Cuozzo,
J.P.Hall,
W.Liu,
L.L.Lin,
and
Y.Zhang
(2003).
Identification of a novel human kinase supporter of Ras (hKSR-2) that functions as a negative regulator of Cot (Tpl2) signaling.
|
| |
J Biol Chem, 278,
47089-47097.
|
 |
|
|
|
|
 |
R.A.Janssen,
P.N.Kim,
J.W.Mier,
and
D.K.Morrison
(2003).
Overexpression of kinase suppressor of Ras upregulates the high-molecular-weight tropomyosin isoforms in ras-transformed NIH 3T3 fibroblasts.
|
| |
Mol Cell Biol, 23,
1786-1797.
|
 |
|
|
|
|
 |
R.Kolesnick
(2002).
The therapeutic potential of modulating the ceramide/sphingomyelin pathway.
|
| |
J Clin Invest, 110,
3-8.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|